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Abstract
Since the advent of highly pathogenic variants of avian influenza virus (HPAIV), the main focus of avian influenza research
has been the characterization and detection of HPAIV hemagglutinin (HA) from H5 and H7 subtypes. However, due to the
high mutation and reassortation rate of influenza viruses, in theory any influenza strain may acquire increased pathogenicity
irrespective of its subtype. A comprehensive antigenic characterization of influenza viruses encompassing all 16 HA and 9
neuraminidase subtypes will provide information useful for the design of differential diagnostic tools, and possibly,
vaccines. We have expressed recombinant HA proteins from 3 different influenza virus HA subtypes in the baculovirus
system. These proteins were used to generate polyclonal rabbit antisera, which were subsequently employed in epitope
scanning analysis using peptide libraries spanning the entire HA. Here, we report the identification and characterization of
linear, HA subtype-specific as well as inter subtype-conserved epitopes along the HA proteins. Selected subtype-specific
epitopes were shown to be suitable for the differentiation of anti-HA antibodies in an ELISA.
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Introduction
Influenza viruses (IV) belong to the family of Orthomyxoviridae,
which are characterized by a segmented and single-stranded
negative sense RNA genome. 8 segments encode 11 viral proteins,
the internal proteins (nucleoprotein, NP; matrix proteins, M1 and
M2; nonstructural proteins, NS1 and NS2; polymerase basic
proteins, PB1, PB1-F2 and PB2; polymerase acidic protein, PA)
and the 2 surface proteins (hemagglutinin, HA and neuraminidase,
NA). While the internal proteins are well conserved among all IV
strains, HA exists in 16 and NA in 9 different subtypes,
respectively. Hence, IV subtype classification is based on the
HA-NA combination. Wild aquatic birds are the natural reservoir
of all HA and NA subtypes of avian IV (AIV), however, the
theoretical subtype spectrum is reduced by a preference of each
HA to be associated with a certain subset of NA subtypes [1].
Several subtypes are able to infect also mammalian hosts, e.g.
humans (H1N1, H2N1, H3N2), horses (H7N7, H3N8) and pigs
(H1N1, H1N2, H3N2, H4N6) [2]. In wild aquatic birds, low
pathogenic AIV (LPAIV) replicates usually asymptomatically in
the intestinal tract. However, mutations in the viral genome of H5
and H7 subtypes, specifically in the HA gene, can lead to the
emergence of highly pathogenic AIV (HPAIV) upon transmission
to susceptible gallinaceous poultry [3]. HPAIV replicate in all
tissues causing peracute to acute fatal disease in poultry and mild
to severe disease in wild birds, depending on the virus strain and
bird species, age and condition [4]. Human influenza strains in
general cause seasonal flu characterized by respiratory symptoms
and, if accompanied by a secondary, mostly bacterial infection,
these IV can lead to fatal cases in young, immunocompromized or
elderly patients. However, the high mutation rate (antigenic drift)
of IV and random reassortation of genomic segments (antigenic
shift) in animals simultaneously infected with different IV subtypes
may lead to an adaptation of HPAIV to the human host,
generating a new highly virulent pandemic strain.
The major factor for IV infectivity is the HA surface protein
that mediates binding of the virus to the host-specific cell surface
receptors a2,3-sialic acid (SA) and a2,6-SA in birds and mammals,
respectively [2]. Thus, HA is the prime target for the development
of new diagnostic, therapeutic and preventive tools, and therefore
a comprehensive antigenic characterization of the IV HA is
needed. In order to rapidly recognize outbreaks of new IV strains
with increased pathogenicity, efficient surveillance is necessary,
which is able to detect all IV subtypes, not only the epidemically
most relevant ones.
Traditional identification and subtyping of IV prescribed by the
Office International des Epizooties (OIE) is based on virus
isolation followed by serological tests, namely agar gel immuno-
diffusion (AGID) to identify any IV, and hemagglutination
inhibition (HI) [5], using HA and NA subtype-specific reference
sera, for subtyping. These traditional methods have been mostly
replaced by molecular methods in recent years, i.e. using RT-PCR
and nucleotide sequencing of the HA and NA genes. Detection
and subtyping of IV antibodies on the other hand still mostly relies
on HI using (inactivated) IV reference strains representing the
entire repertoire of HA and NA subtypes. ELISA-based antibody
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ELISA employ only 1 individual antigen [6,7,8] and are,
tentatively, monospecific for a selected HA or NA subtype. Novel
technologies such as multiplex fluorescent microsphere immuno-
assays (FMIA) employing more than 1 IV antigen [9] show, that
antibody differentiating immunoassays are possible. Until now no
multiplex approach is available for the subtyping of IV antibodies
based on HA and NA serotype differentiation.
Initial antigenic characterization of IV HA protein for basic
understanding of serological assays has revealed the importance of
epitope conformation at the receptor-binding site formed by HA
monomer folding and trimerisation [10]. The use of correctly
folded HA was considered as a prerequisite for the detection and
characterization of neutralizing epitopes, which are the mayor
target of the virus neutralizing humoral immune response. This
was supported by the observation that synthetic HA peptides failed
to function as epitopes recognized by neutralizing monoclonal
antibodies [11,12,13,14]. However, recent findings that neutral-
izing antibodies are produced upon experimental vaccination with
a bacterially expressed, detergent-treated and unfolded HA have
shown that a virus-neutralizing immune response is possible
independent of conformational epitope formation [15,16]. Recent
studies demonstrated that antibodies binding to linear HA epitopes
achieve neutralizing activity by inhibiting the pH-dependent HA
conformational rearrangement [17,18,19]. These findings show
the existence of linear epitopes on IV HA and support their role
during humoral immune response. The question is raised, if such
epitopes represent a new repertoire of tools for serologic
surveillance assays and if they are valid targets for serologic IV
subtype differentiation. If they are present in a sufficient number,
they may stimulate antibody production high enough to be
detectable independent of the property to be neutralizing or not.
Thus, linear epitopes present on HA should be included in the
antigenic characterization of IV.
With the antigenic analysis of all HA and NA subtypes, a
comprehensive picture of AIV HA antigenicity can be established
which can be used to design highly specific differentiation tools.
Several studies have provided evidence that both HA subtype-
specific as well as inter subtype-conserved epitopes do exist
[20,21,22,23,24]. The primary aim of the present study was to
determine, whether AIV subtype-specific linear epitopes on the
HA protein can be detected with sera from animals immunized
with recombinant AIV HA of the homologous subtype. We show
that numerous linear, both inter subtype-conserved as well as
subtype-specific epitopes exist on HA proteins derived from
different AIV HA subtypes, based on differences in the reactivity
patterns of homologous and heterologous antisera. Epitope
mapping was performed by peptide scanning using libraries of
overlapping peptides representing the entire HA from 3 different
HA subtypes (H4, H5, H12), and rabbit antisera raised against the
corresponding recombinant HA proteins. This approach allowed
to elucidate the repertoire of subtype-specific and inter subtype-
conserved epitopes among the studied AIV surface proteins. Our
data provide evidence that all 3 HA subtypes analyzed carry linear
epitopes in both the HA1 and HA2 ectodomains. In addition,
synthetic peptides representing such epitopes were shown to be
suitable as subtype-specific antigens for differential ELISA
development.
Results
To test the effect of recombinant protein conformation on
expression and secretion efficiency, recombinant H5, H4 and H12
HA was expressed via recombinant baculoviruses either as full
length protein or as transmembrane domain deleted (DTMD)
peptide containing the HA1 and HA2 ectodomains (Fig. 1A and
B). No significant difference in secretion efficiency was observed
using either the authentic AIV or the HBM secretion signal.
Recombinant proteins lacking the TMD were efficiently expressed
and secreted into the cell culture supernatant, and could be used as
starting material for His tag affinity purification. Buffer exchange
from cell medium to carbonate buffer and purification using
HisTrap-Ni-NTA columns with an imidazole gradient resulted in
highly pure and concentrated HA protein fractions, yielding up to
1 mg recombinant protein per 50 ml expression culture (Fig. 1C-
E). This preparations were used to immunize rabbits. Pre-immune
sera of all rabbits did not recognise the recombinant HA proteins
whereas sera after immunization were highly reactive with all 3
recombinant HA, both before (Fig. 2A-D) and after affinity
purification (Fig. 2E-G) of the HA proteins.
Epitope mapping: Homologous system
To identify peptides that represent epitopes recognised by
polyclonal antibodies, and to differentiate between subtype-specific
and inter subtype-conserved epitopes, peptide scanning was
performed with 15 amino acid (aa) long peptides overlapping by
12 aa and representing the complete set of linear epitopes of each
expressed HA on a nitrocellulose dot blot membrane. Unspecific
signals resulting from direct binding of the secondary antibody to
the peptides were subtracted from the raw signal in every
experiment to obtain sera-specific net reactivities. These signal
intensities, shown in arbitrary units, were normalized to the
highest value set as 100%. The normalized intensities of all
peptides representing 1 HA protein were plotted against the
peptide numbers along the HA protein in a diagram to show
antigenicity curves for each of the recombinant H5, H4 and H12
HA. H5 contained the fewest reactive peptides and H4 the most.
However, the integrated intensities were higher for H5 than for
H4 and H12. Furthermore, epitopes present on H5 HA were
found to be more concentrated to separated epitope-containing
areas (Fig. 3A and B) whereas epitopes on the H4 and the H12 HA
were found to be more evenly distributed along the entire protein
(data not shown).
To generate an antigenic map based on the protein primary
structure, the signal intensities from the antigenicity plots were
superimposed onto the aa sequences of the expressed proteins by
performing a semi quantitative and color-coded visualization of
reactive peptides. Interestingly, some peptides reacted strongly
whereas the next, overlapping peptide reacted only weakly or not
at all with the rabbit sera. Epitope scanning was analyzed first by
considering the complete length of strongly reacting peptides
(Fig. 4A). Such an analysis allows generating a map of the
localisation and distribution of epitope-containing regions (Fig. 5A).
An alignment of the aa sequences of all 3 antigens used indicates
that antibodies presented in the homologous antisera recognize the
majority of peptides of H4 and H12 along the HA1 chain (aa 130
to 350), whereas in H5, the binding sites were allocated in clearly
separated regions located within the HA1. The HA2 ectodomain
shared only 1 antibody binding region in all 3 antigens.
To increase the resolution of antibody binding sites in all
reactive peptides, weakly or non-reacting peptides were subtracted
from neighbouring highly reactive ones (Fig. 4B). The peptides
were color-coded according to their normalized dot blot intensities
in steps of 100% to 70%, 70% to 40%, 40% to 20% and 20% to
10% integrated intensity, respectively. Furthermore, regions with
overlapping peptides of different signal intensities were color-
coded according to the less reactive peptide (net signal intensity) in
order to identify antibody binding sites within the epitopes [25].
AIV Subtype Specific Epitopes
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binding sites differs within conserved antibody binding regions in
the HA H4, H5 and H12 (Fig. 5B).
Epitope mapping: Heterologous system and
subtype-specific epitopes
In Western blot analyses, all 3 sera recognized all 3 antigens. In
a second analysis the H5, H4 and H12 HA membranes were
scanned for subtype-specific and cross-reactive linear epitopes in 2
different approaches. First, all membranes were tested individually
with all sera to visualize cross-reactive epitopes, as shown for the
H5 antigen (Fig. 3C). Additionally, sera against 1 of the 3 antigens
were tested on membranes representing the 2 other antigens, to
visualize the cross reactivity of the sera as shown for the serum anti
H5 HA (Fig. 3D). The integrated membrane signals were plotted
as for the homologous sera. Subtype-specific epitopes were
obtained by subtracting the heterologous from the homologous
signals. The reduced number of reactive peptides in H5 HA and
the increased number of reactive peptides in H4 HA and H12 HA
found previously in the homologous mapping correlated with
fewer epitopes remaining on H5 compared to H4 and H12 HA
after subtraction of the heterologous from the homologous sera
signals (Fig. 6). When the epitope reactivities were compared, as
shown in figure 5B and figure 6, in all 3 antigens the subtype-
specific epitopes reacted moderately to strongly in the homologous
systems (see also suppl. Table S1).
ELISA
Based on the epitope mapping results the following peptides
were selected as HA subtype-specific antigens in ELISA: H5:
biotin-Ttds-ANNSTEQVDTIMEKNVTVTHAQD-OH; H4: bi-
otin-Ttds-DSEMNKLFERVRRQLRENAEDKGNGCF-OH and
for H12: biotin-Ttds- FTWAIHHPPTSDEQV-OH. As shown in
Fig. 7, antibody subtype differentiation was possible both with the
polyclonal rabbit sera (Fig. 7A-C) and with serum derived from a
chicken that had been vaccinated against H5N9 (Fig 7D) in the
indirect ELISA format, whereas in the blocking ELISA format no
differentiation was possible (data not shown).
Discussion
The HA of the 3 AIV HA subtypes H4, H5, and H12 were
expressed as soluble recombinant 6xHis-tagged fusion protein in
the baculovirus system. These 3 subtypes were chosen not
primarily based on their epidemiological relevance, but because
their HA genes are genetically quite different among each other,
making it more likely that the recombinant HA proteins exhibit
numerous differences in their epitopes. Immunization of rabbits
with Ni-NTA affinity-purified recombinant HA resulted in the
production of highly reactive antisera. However, these polyclonal
sera could not be used for subtype differentiation using full-length
antigens, because many of the epitopes presented on the antigens
reacted at least weakly with the heterologous sera (Fig. 2B-G,
Fig. 3C and D). Remarkably, the reactivity of the sera in Western
blot analysis was even stronger with the heterologous antigens
compared to their respective homologous antigens. This could be
due to different antibody titers in the sera used or to different total
antigen avidities caused by different numbers of homo- and
heterologously reactive epitopes accessible on antigens transferred
onto the nitrocellulose membrane. Nevertheless, the recognition of
AIV HA subtype-specific and intra subtype-conserved epitopes in
the form of overlapping linear synthetic peptides on PepSpot
membranes with these sera was possible.
Figure 1. Construction and purification of recombinant AIV HA.
Schematic drawing of the full-length HA protein and the relative
location of the domains (black boxes) used for recombinant protein
expression. The honeybee melittin (HBM) secretion signal (SS) is shown
in grey. (B) Schematic illustration of recombinant HA proteins, shown as
fusion of subtype-specific HA domains with the AIV ss or the HBM ss
and a C-terminal 6xHis tag. (C-E) Western blot and SDS-PAGE analyses of
cell culture supernatant (ccs) after Ni-NTA affinity chromatography. All
proteins were secreted in the ccs in an uncleaved form and purified
following an identical purification procedure. Differences in the number
of positive elution fractions in the Western blot result from different
quantities of recombinant protein bound to the Ni-NTA-column. SDS-
PAGE results indicated that the most concentrated elution fractions
contained almost exclusively the purified HA. Purification fractions are
indicated with numbers, F= flow through fraction, L= load fraction.
doi:10.1371/journal.pone.0009097.g001
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endosomal pH shift during infection, antibodies to conforma-
tional sites can be classified in 3 categories depending on their
ability to recognize only the neutral form, only the acidified form,
or both. Thus, the repertoire of linear epitopes in the analyzed
HA proteins and of antibodies in the rabbit sera against the
recombinant HA proteins found in this study might be similar to
the repertoire of linear epitopes in and antibodies against native
AIV.
Neutralizing epitopes in the HA1 receptor binding site are not
conserved between subtypes [24]. Our results indicate that HA1
contains subtype-specific linear epitopes as well with a subtype-
dependent variability in number and localisation among H4, H5
and H12 HA. The HA2 peptides of H4, H5 and H12 HA revealed
only few subtype-specific epitopes (1 in H5 HA, 2 in H4 HA and 4
in H12 HA, respectively). This finding supports the model, that the
fusion peptide-containing HA2 is less variable and harbours the
majority of inter subtype-conserved epitopes [24].
Figure 2. Western blot analyses with pre-immune sera and antisera derived from immunized rabbits. Unpurified recombinant H5 HA,
H4 HA and H12 HA and a C-terminal 6x His tagged porcine IFN were blotted onto nitrocellulose membranes and analyzed with a monoclonal
antibody against the His tag (A) or with serum from the 2nd bleeding (56 days post immunisation) from rabbits, immunized either with purified
recombinant HA H5 (B), H4 (C) or H12 (D), respectively. Purified recombinant H5, H12 and H4 HA were blotted onto nitrocellulose membranes and
analyzed with pre-immune rabbit sera (PI), a monoclonal antibody against the His tag and serum from the 3rd bleeding (114 days post infection) from
rabbits, immunized with purified recombinant HA H5 (E), H4 (F) or H12 (G).
doi:10.1371/journal.pone.0009097.g002
Figure 3. Visualization of data obtained from the peptide scanning analyses. The signal intensity of each peptide on the dot blot membrane is
shown as integrated intensity after subtraction of unspecific background and secondary antibody-related signals. Relative reactivity values are normalized
by setting the highest value of each experiment at 100%. Sera were tested on membranes containing their homologous antigen. Examples of H5 HA dot
blot and homologous reactivity patterns obtained by 3-fold probing and stripping of the membrane are shown in A and B, respectively. Cross-reactivity
of sera was identified by testing each serum with each heterologous membrane; a representative plot obtained with sera against H5, H4 and H12 on the
membrane containing H5-specific peptides is shown in C. Furthermore, cross-reactive epitopes were also identified by testing each of the sera on their
respective heterologous membranes, as shown for serum against H5 on membranes representing H4 or H12 (D).
doi:10.1371/journal.pone.0009097.g003
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exist in AIV HA some of which are subtype-specific, whereas
others are conserved among several subtypes. The location of the
antibody-binding peptides, but not their sequence, was found to be
conserved in all 3 antigens, suggesting that these peptides represent
protein regions on the surface of the folded protein accessible to
antibodies. The antibody binding sites differ within these
conserved antibody binding regions in the HA H4, H5 and H12
(Fig. 5B). The lower number of epitopes found in H5 compared to
H4 and H12 might explain the observation that in a mammalian
system H5 HA is a less immunogenic antigen than HA from other
subtypes [26]. Interestingly, this effect seems to be less pronounced
in poultry vaccines [27]. The reasons for this are unknown. Upon
analysis of the overall antigenic pattern recognized by hyperim-
mune rabbit sera compared to that recognized by hyperimmune
chicken sera, no significant differences were observed (data not
shown). This indicates that the species dependent immunogenicity
of H5 HA cannot be explained by differences in the antigenic
recognition of the aa primary structure. One explanation could be
that the traditional formulation of inactivated whole-virus H5N1
vaccines [26,27] contains additional epitopes of other viral
proteins that may stimulate the immune response in a host
species-dependent manner.
The peptide scanning approach provided informations which
could be useful for the development of subtype-specific antibody
differentiation tests. The antigenicity curves generated (Fig. 3C
and D) show peptides from H5 that react specifically with antisera
specific to H5. Such peptides can be assessed for their suitability
for subtype-specific antibody differentiation. Additionally, the
curves also show peptides from H5 HA with high reactivity to
antisera specific to H4, H5 and H12 HA. These peptides mediate
serologic cross-reactivity among different subtypes, hence they
may be interesting candidates for the development of tailored
multi HA-specific vaccines based on a combination of suitable
recombinant peptide antigens. However, the analysis of the
immunogenicity of these peptides was beyond the scope of this
study.
Some of the peptides that were recognised in the peptide
scanning analysis contain N-glycosylation sites. Since the insect
cell expression system is known to be suitable for eukaryotic
posttranslational glycan modifications, it is likely that the antigens
used for immunization were glycosylated, even if insect cell
glycosylation is not authentic to but a rudimentary form of
mammalian glycosylation [28]. However, the fact that unglycosy-
lated synthetic linear peptides are recognised by the sera raised
against the recombinant HA proteins indicates, that epitope
glycosylation is not a prerequisite for the detection by polyclonal
antibodies; hence, epitope antigenicity is likely to be dependent on
the protein primary structure, independent of their glycosylation
state.
The development of new technologies for the generation of
monoclonal antibodies, the expression of native recombinant
antigens as well as improved analyses of protein structure and
modification led to many detailed and important insights into the
correlation of IV HA structure and antigenicity. However, after
initial studies carried out in the 1980s the concept of linear
epitopes to be used for AIV diagnostics and control by vaccination
has not been further examined. Our data clearly show that such
epitopes exist and could be further evaluated for their suitability as
diagnostic or vaccine tools. During humoral immune response,
viral antigens are presented to B cells either as intact or as recycled
antigens, depending on the type of antigen presenting cell involved
(for a comprehensive review see [29]). Viral antigen can be
recycled and presented as short peptides that differ in their
conformation from the native antigen. This might explain the
selection of B cell clones that express antibodies reacting
independent of the native antigen conformation. Recent studies
have shown that some linear epitopes are immunogenic and can
induce neutralizing antibodies [15,18]. Such antibodies against
linear epitopes should be detectable in serologic diagnostic tests. In
this study, rabbit as well as chicken sera were differentiable in an
indirect ELISA employing H4, H5 and H12 HA-specific peptide
antigens.
For practical purposes, it should be possible to examine sera
from different host species in a blocking ELISA, where antibodies
in positive test sera block antibody binding sites for the antibodies
present in the indicator serum. In this study, however, it was not
possible to set up a blocking ELISA based on the subtype-specific
HA peptide antigens and the rabbit sera as source for indicator
antibodies. Even when the rabbit sera were diluted up to 1:6400,
and a chicken serum known to contain high titers of H5 antibodies
was used in a high concentration (i.e. diluted 1:5), a subtype-
specific differentiation of the chicken antibodies was not possible
(data not shown). This might be due to a high avidity of the
antibodies presented in the H5 rabbit serum leading to a
displacement of chicken antibodies. Eventually, this problem
could be solved by the use of monoclonal antibodies reactive to the
used peptide, instead of the polyclonal sera.
Our data provide evidence that IV HA proteins harbour more
linear epitopes than found until now, and that some of these
epitopes are recognized as subtype-specific by antibodies in
hyperimmune animal sera. In addition, to our knowledge, this is
the first study showing that AIV subtype-specific antibody
differentiation is possible in an indirect ELISA assay using
polyclonal sera and synthetic linear peptides representing
subtype-specific epitopes. Based on these findings, further
validation studies are required based on more than 1 serum
Figure 4. Principle of generation of semi-quantitative antigenic
maps. Integrated intensities from peptide scanning analyses were
transferred to the aa sequence as shown here for the HA aa sequence
from HPAIV A/tufted duck/Switzerland/V504/06(H5N1) within the
sequence range from aa position 20 to 63, as indicated. (A) Semi
quantitative display of the gross signal intensities in color-coded
categories: 100%–40% (red), 40%–30% (yellow). (B) Semi-quantitative
display of the net signal intensities in color code categories: 100%–70%
(red), 70%–40% (green) and 40%–20% (light blue).
doi:10.1371/journal.pone.0009097.g004
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the validation of such an antibody subtype differentiation ELISA
is, to determine if the number of subtype-specific linear epitopes
per subtype is reduced by the inclusion of additional subtypes in
the peptide scanning analysis, and if the differential recognition of
subtype-specific epitopes, in terms of ELISA sensitivity and
Figure 6. Subtype-specific epitopes. Integrated intensities from peptide scanning were transferred to the aa sequence of each AIV HA after
subtraction of the heterologous from the homologous sera signals (H5, light blue; H4, green; H12, pink). All remaining epitopes are shown
independent of their signal intensity in the homologous system.
doi:10.1371/journal.pone.0009097.g006
Figure 5. Antigenic maps of AIV HA domains reacting with their homologous sera. Color code indicates (A) the gross signal intensities
found (compare to Fig. 4A, 100%–40% (red) and 40%–30% (yellow)) and (B) the net signal intensities found (compare to Fig. 4B, 100%–70% (red),
70%–40% (yellow) and 40%–20% (light blue)).
doi:10.1371/journal.pone.0009097.g005
AIV Subtype Specific Epitopes
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raised against genetically more closely related IV subtypes or sera
from multiple IV-infected hosts. It might be necessary to use a
different set of subtype-specific peptide antigens or a combination
of several antigens in a final ELISA protocol. Therefore, more
efforts should be undertaken to investigate the role of linear
epitopes on IV surface proteins and their classification in subtype-
specific and inter subtype-conserved epitopes in order to improve
AIV diagnostic and vaccination concepts. Such studies involving
the majority of the remaining HA subtypes are currently under
way.
Materials and Methods
Ethics Statement
Animal experiments have been conducted according to the
national and institution’s guideline (SR 455.1, Tierschutzverord-
nung (TSchV) 23. April, 2008) of the Swiss government.
Isolation of viral RNA, cloning of recombinant HA and
generation of recombinant baculoviruses
HPAIV A/tufted duck/Switzerland/V504/06(H5N1) originat-
ed from a dead tufted duck found during the H5N1 HPAIV
epidemic in 2006 in Switzerland [30]. LPAIV A/mallard/
Switzerland/WV4060166/2006(H12N2) was isolated from a
healthy mallard in Switzerland (Baumer, submitted). The virus
isolate A/duck/Cz/56(H4N6) (LP) was kindly provided by R.
Hoop, Swiss National Reference Laboratory for Avian and Rabbit
Diseases, Vetsuisse Faculty, Zurich. Total RNA was extracted
from these isolates with TrizolH, hybridised with primer SZA
+ [31]
at 65uC for 10 min and reverse transcribed into cDNA with
SuperScript
TM III Reverse Transcriptase (Invitrogen) for 10 min
at room temperature followed by 1h at 50uC.
The full-length ORF of the HA genes was amplified using primer
SZAHA
+ and SZAHA
- [32] and PlatinumH Taq DNA polymerase
(Invitrogen) in a touch-down PCR [30]. Amplified HA cDNA was
agarose gel purified and subsequently cloned into the vector plasmid
pCRH 4-TOPOH (Invitrogen) and sequenced. Full-length HA ORF
sequences were either newly deposited or already available on
GenBank under the accession numbers AB295611 (H4), EF547197
(H5), and GQ415321 (H12). The HA ORF were reamplified with
Pfu Turbo DNA Polymerase (Sigma) in fusion with a C-terminal
6xHis tag and excluding the transmembrane domain (H5-DTMD
and H12-DTMD) as well as the authentic secretion signal sequence
(H4-ECD) with primers AI_H5_HA_BamH1fw (atggatccgatg-
gaaaaaatagtgcttcttc) and AI_H5_ECDHind3rev (ataagcttaatggt-
gatggt gatggtgttggtaagttcctattgattcc), H4_ECD_BamH1fwd
(agatccgcaaaactacacaggaaaccctg) and AI_H4_ECD_PstIrev (atctg-
cagttaatggtgatggtgatggtggtccttatatccctgggtcaatt), or AI_H12_HA_-
BamH1fwd (atcggatccgatggagaagttcattgtactgag) and AI_H12_-
HA_SpeIrev (atcactagttaatggtgatggtgatggtgtttgtatgtagaattctcttcaag),
respectively. Truncated HA genes were subsequently cloned in
pCRH 4-TOPOH (Invitrogen), resequenced and transferred by
DNA restriction with enzymes cutting at the primer-encoded
restriction sites and ligation into the corresponding restriction sites
in the baculovirus expression vector pFastBac1 (Invitrogen). For the
N-terminal fusion of the truncated HA ORF to the signal sequence
of the honeybee melittin (HBM) in order to enhance secretion of the
recombinant HA protein [33], the expression vector pFastBacHBM
was designed. A DNA cassette encoding the polypeptide
MKFLVNVALVFMVVYISYIYA was cloned into the pFastBac1
vector at the authentic translation initiation site of the polyhedrin
gene. To this end a PCR fragment was generated with primers
FBacMBacU (gttggctacgtatactccggaatattaatagatcatggagataattaaaat-
gataacca) and BacHBML (ctcggatccgcatagatgtaagaaat) using plas-
mid pMelBacB (Invitrogen) as template. This DNA fragment was
digested with the restriction endonucleases SnaBI and BamHI and
ligated into the corresponding sites of pFastBac1. In this vector, the
gene of interest must be inserted in frame with the HBM signal
sequence at any restriction site upstream of the stop codon-
containing SpeI site in the multiple cloning site. The insertion was
verified by nucleotide sequencing. Generation and amplification of
recombinant baculoviruses was performed with the Bac-to-Bac-
System (Invitrogen) according to the manufacturer’s protocol.
Figure 7. Antibody differentiation with polyclonal animal sera against different AIV HA subtypes tested in ELISA. (A) HA subtype-
specific biotinylated peptide antigens (H5: biotin-Ttds-ANNSTEQVDTIMEKNVTVTHAQD-OH; H4: biotin-Ttds-DSEMNKLFERVRRQLRENAED KGNGCF-OH
and for H12: biotin-Ttds-FTWAIHHPPTSDEQV-OH) were coated on ELISA plates at indicated amounts and tested with the 3 rabbit antisera (diluted
1:500); H5 antigen (A), H4 (B), and H12 (C). Antigens H4, H5 and H12 HA were also tested with a chicken serum against H5 HA (diluted 1:10) (D).
doi:10.1371/journal.pone.0009097.g007
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For expression of recombinant HA, suspension cultures with 20
million High Five cells (Invitrogen) were infected with recombinant
baculovirus at an m.o.i. of 10 pfu/cell for 2 h at RT, shaking. Cells
were then incubated at 27uC on a shaker (150 rpm) in ESF 921
(Expression Systems, Woodland, CA, U.S.A.) or Express Five serum
free medium (Gibco). After 96 h cells were separated from the cell
culture supernatant (ccs) by centrifugation (10 min, 10006g, 4uC),
resuspended in carbonate buffer (100 mM carbonate, 500 mM
N a C l ,1 0m Mi m i d a z o l e ,p H9 . 6 ,w i t hp r o t e o l y s i si n h i b i t o rP 8 8 4 9
(Sigma) 1 ml/10
6 c e l l s )a n ds o n i c a t e d3 610 sec on ice. Sonicated
cells were centrifuged for 15 min at 14000 rpm and 4uCa n d
resuspended in carbonate buffer. Aliquots of the ccs, the supernatant
after sonication and the resuspended sonicated cells were used for
SDS-PAGE and Western blot analysis to determine expression
efficiency and solubility of the HA proteins. Positive ccs were buffer-
exchanged into carbonate buffer prior to purification using a stirred
ultrafiltration cell (Amicon) or by dialysis. Recombinant HA were
purified with HisTrap HP 1 ml Ni-NTA-columns and the AEKTA
FPLC system (Amersham Biosciences). Columns were equilibrated
with carbonate buffer and loaded with the buffer-exchanged
recombinant protein preparations at a flow rate of 1 ml/min,
washed with 20 ml carbonate buffer containing 10 mM imidazole
(1 ml/min) and eluted with an imidazole gradient from 10 mM to
500 mM in 20 ml carbonate buffer (1 ml/min). 1 ml eluate
fractions were collected and analyzed by Western blot. Fractions
containing the affinity-purified HA were pooled and concentrated
with CentriconH YM-10 filters (Amicon).
SDS-PAGE and Western Blot
SDS-PAGE was performed with the Mini Protean Electropho-
resis system (Bio-Rad) and analyzed with the Odyssey Infrared
Imaging System (LI-COR Biosciences). For Western blot, proteins
were blotted after SDS-PAGE onto nitrocellulose membranes
(Porablot NCL, Macherey-Nagel) using a Trans Blot SD transfer
cell (Bio-Rad). After blocking with blocking buffer (LI-COR
Biosciences), the recombinant HA were detected with an anti
6xHIS tag monoclonal antibody (Roche) diluted 1:400 in blocking
buffer and a polyclonal goat anti-mouse IRDyeH 800CW conjugate
(LI-COR Biosciences) diluted 1:10.000 in blocking buffer and the
OdysseyH Infrared Imaging System (LI-CORH Biosciences).
Immunization of rabbits
Before immunization, the concentrated HA fractions were dialyzed
in PBS (8.1 mM Na2HPO4,1 . 4 m MK H 2PO4,1 3 7 m MN a C l ,
2.7 mM KCl, pH 7.3) with a Slide_A_Lyzer Dialysis Cassette, 3.500
MWCO, 0.1–0.5 ml capacity (Pierce). 200–500 mgo fa n t i g e nw e r e
used for each of 3 consecutive immunizations of female New Zealand
White Rabbits, 1.8 kg (Charles River Laboratories) every 4 weeks.
Epitope mapping
PepSpotsH membranes for the mapping of linear and confor-
mational epitopes were obtained from jpt Peptide Technologies
GmbH, Germany. The mapping of linear epitopes was performed
following the manufacturer’s protocol using rabbit sera, diluted
1:1000 and goat anti rabbit IRDyeH 800CW conjugate. The
signals on the PepSpotsH membranes were quantified with the
Odyssey Infrared Imaging System (LI-COR Biosciences).
Epitopes were identified in a homologous and a heterologous
way. In the homologous system serum against H5 HA was tested
on membranes displaying peptides derived from H5 HA, serum
against H4 HA on membranes with peptides derived from H4 HA
and serum against H12 HA on membranes with peptides derived
from H12 HA. In the heterologous system polyclonal serum raised
against 1 of the 3 HA antigens was tested on membranes
displaying the 2 other antigens (e.g. serum against H5 was tested
on membranes displaying H4 and H12 HA).
ELISA
Peptide ELISA was performed using Reacti-Bind
TM Streptavi-
din High Binding Capacity Coated 96-Well Plates (Pierce) and
biotin-labeled synthetic subtype-specific peptides as antigens.
Plates were washed with TBS washing buffer (25 mM Tris,
150 mM NaCl; pH 7.2, 0.1% BSA, 0.05% Tween-20) and coated
over night at 4uC with peptides diluted in washing buffer. After
coating, plates were washed and incubated either with the rabbit
antisera or with an anti-H5N9 chicken serum, generated by
intramuscular vaccination of chicken with a commercial inacti-
vated H5N9 poultry vaccine and kindly provided by our in-house
vaccine registration department, diluted in washing buffer for 1 h
at 37uC. For indirect ELISA, sera were removed and plates were
washed in washing buffer prior to incubation for 1 h 37uC with
species-specific HRP-conjugates (polyclonal swine anti-rabbit
HRP, Dako Cytomation) diluted 1:4000 in washing buffer; or
undiluted anti-chicken/turkey hen-IgY-HRP (Labor Diagnostik
Leipzig, Germany). After removal of the conjugate and final
washing, plates were incubated at room temperature with ABTS
substrate containing 1% of 1% H2O2. OD values were recorded
after 15, 30, 45, 60, 90 and 120 minutes at 405 nm. For blocking
ELISA, plates were incubated first with test serum and then with
rabbit serum without to remove the test serum, 1 h 37uC each.
Conjugates and substrate were added and measurements were
performed as described for indirect ELISA.
Supporting Information
Table S1 Epitope-displaying peptides. Subtype-specific epitope
sequences are underlined. Reactivities were quantified and
categorised into 100% to 70% (++) and 70% to 30% (+). Peptides
containing glycosylation sites are indicated with underlined
numbers.
Found at: doi:10.1371/journal.pone.0009097.s001 (0.04 MB
XLS)
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